Rolf Kaiser

InstitutionUniversity of Cologne
AddressCologne
Germany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 1 publications in Spetember 2020 and February 2021 and June 2021 and August 2021
    All Publications
    Bar chart showing 184 publications over 20 distinct years, with a maximum of 16 publications in 2014 and 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Joachim A, Dewald F, Suárez I, Zemlin M, Lang I, Stutz R, Marthaler A, Bosse HM, Lübke N, Münch J, Bernard MA, Jeltsch K, Tönshoff B, Weidner N, Kräusslich HG, Birzele L, Hübner J, Schmied P, Meyer-Bühn M, Horemheb-Rubio G, Cornely OA, Haverkamp H, Wiesmüller G, Fätkenheuer G, Hero B, Kaiser R, Dötsch J, Rybniker J. Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trial. EClinicalMedicine. 2021 Sep; 39:101082. PMID: 34458708.
      Citations:    
    2. Kitanovski S, Horemheb-Rubio G, Adams O, Gärtner B, Lengauer T, Hoffmann D, Kaiser R. Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2. BMC Public Health. 2021 06 21; 21(1):1178. PMID: 34154549.
      Citations: 2     Fields:    Translation:HumansCells
    3. Müller L, Ostermann PN, Walker A, Wienemann T, Mertens A, Adams O, Andree M, Hauka S, Lübke N, Keitel V, Drexler I, Di Cristanziano V, Hermsen DF, Kaiser R, Boege F, Klein F, Schaal H, Timm J, Senff T. Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting. Eur J Clin Microbiol Infect Dis. 2021 May; 40(5):1063-1071. PMID: 33534090.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    4. Eberhardt KA, Meyer-Schwickerath C, Heger E, Knops E, Lehmann C, Rybniker J, Schommers P, Eichenauer DA, Kurth F, Ramharter M, Kaiser R, Holtick U, Klein F, Jung N, Di Cristanziano V. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients. Viruses. 2020 09 18; 12(9). PMID: 32962125.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    5. Lübke N, Jensen B, Hüttig F, Feldt T, Walker A, Thielen A, Däumer M, Obermeier M, Kaiser R, Knops E, Heger E, Sierra S, Oette M, Lengauer T, Timm J, Häussinger D. Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118R. N Engl J Med. 2019 08 29; 381(9):887-889. PMID: 31461601.
      Citations: 7     Fields:    Translation:HumansCells
    6. Vinken L, Fransen K, Cuypers L, Alexiev I, Balotta C, Debaisieux L, Seguin-Devaux C, García Ribas S, Gomes P, Incardona F, Kaiser R, Ruelle J, Sayan M, Paraschiv S, Paredes R, Peeters M, Sönnerborg A, Vancutsem E, Vandamme AM, Van den Wijngaert S, Van Ranst M, Verhofstede C, Stadler T, Lemey P, Van Laethem K. Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium. Front Microbiol. 2019; 10:613. PMID: 30972053.
      Citations: 4     
    7. Sarfo FS, Castelnuovo B, Fanti I, Feldt T, Incardona F, Kaiser R, Lwanga I, Marrone G, Sonnerborg A, Tufa TB, Zazzi M, De Luca A. Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinics. J Infect. 2019 05; 78(5):402-408. PMID: 30849438.
      Citations: 1     Fields:    Translation:Humans
    8. Reck M, Kerr KM, Grohé C, Manegold C, Pavlakis N, Paz-Ares L, Huber RM, Popat S, Thatcher N, Park K, Hilberg F, Barrueco J, Kaiser R. Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity? Future Oncol. 2019 Apr; 15(12):1363-1383. PMID: 30758227.
      Citations: 4     Fields:    Translation:Humans
    9. Wiesmann F, Ehret R, Naeth G, Däumer M, Fuhrmann J, Kaiser R, Noah C, Obermeier M, Schalasta G, Tiemann C, Wolf E, Knechten H, Braun P. Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV-1 Reference Assay. J Clin Microbiol. 2018 10; 56(10). PMID: 30068537.
      Citations: 4     Fields:    Translation:HumansCells
    10. Herrmann A, Sandmann L, Adams O, Herrmann D, Dirks M, Widera M, Westhaus S, Kaiser R, di Cristanziano V, Manns MP, Korth J, Richter N, Anastasiou O, Timm J, von Hahn T, Ciesek S. Role of BK polyomavirus (BKV) and Torque teno virus (TTV) in liver transplant recipients with renal impairment. J Med Microbiol. 2018 Oct; 67(10):1496-1508. PMID: 30136921.
      Citations: 4     Fields:    Translation:HumansCells
    11. Reck M, Mellemgaard A, Novello S, Postmus PE, Gaschler-Markefski B, Kaiser R, Buchner H. Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study. Onco Targets Ther. 2018; 11:4573-4582. PMID: 30122949.
      Citations: 7     
    12. Knops E, Sierra S, Kalaghatgi P, Heger E, Kaiser R, Kalinina OV. Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms. Genes (Basel). 2018 Jul 06; 9(7). PMID: 29986475.
      Citations: 1     Fields:    
    13. Döring M, Büch J, Friedrich G, Pironti A, Kalaghatgi P, Knops E, Heger E, Obermeier M, Däumer M, Thielen A, Kaiser R, Lengauer T, Pfeifer N. geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data. Nucleic Acids Res. 2018 07 02; 46(W1):W271-W277. PMID: 29718426.
      Citations: 10     Fields:    Translation:HumansCells
    14. Demir M, Phiri S, Heger E, Heller T, Kaiser R, Chaweza T, Fätkenheuer G, Steffen HM, Neuhann F. Prevalence of Anti-HBs Without Anti-HBc Among HIV-Infected Adults Initiating Antiretroviral Therapy in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):e14-e15. PMID: 29543637.
      Citations:    Translation:Humans
    15. Bastys T, Gapsys V, Doncheva NT, Kaiser R, de Groot BL, Kalinina OV. Consistent Prediction of Mutation Effect on Drug Binding in HIV-1 Protease Using Alchemical Calculations. J Chem Theory Comput. 2018 Jul 10; 14(7):3397-3408. PMID: 29847122.
      Citations: 3     Fields:    Translation:HumansCells
    16. Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC Infect Dis. 2018 06 01; 18(1):251. PMID: 29859062.
      Citations: 12     Fields:    Translation:HumansCells
    17. Stecher M, Chaillon A, Eberle J, Behrens GMN, Eis-Hübinger AM, Lehmann C, Jablonka A, Bogner J, Fätkenheuer G, Spinner CD, Wasmuth JC, Kaiser R, Mehta SR, Vehreschild JJ, Hoenigl M. Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016. Sci Rep. 2018 05 01; 8(1):6799. PMID: 29717148.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    18. Matsuda M, Louvel S, Sugiura W, Haas A, Pfeifer N, Yokomaku Y, Iwatani Y, Kaiser R, Klimkait T. Performance Evaluation of a Genotypic Tropism Test Using HIV-1 CRF01_AE Isolates in Japan. Jpn J Infect Dis. 2018 Jul 24; 71(4):264-266. PMID: 29709982.
      Citations:    Fields:    Translation:HumansCells
    19. Forster M, Hackshaw A, De Pas T, Cobo M, Garrido P, Summers Y, Dingemans AC, Flynn M, Schnell D, von Wangenheim U, Loembé AB, Kaiser R, Lee SM. A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3). Lung Cancer. 2018 06; 120:27-33. PMID: 29748012.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    20. Boucher CA, Bobkova MR, Hung CC, Kaiser R, Marcelin AG, Streinu-Cercel A, van Wyk J, Dorr P, Vandamme AM. State of the Art in HIV Drug Resistance: Surveillance and Regional Gaps. AIDS Rev. 2018 Jan-Mar; 20(1):43-57. PMID: 29628514.
      Citations: 1     Fields:    Translation:HumansCells
    21. Boucher CA, Bobkova MR, Geretti AM, Hung CC, Kaiser R, Marcelin AG, Streinu-Cercel A, van Wyk J, Dorr P, Vandamme AM. State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap. AIDS Rev. 2018 Jan-Mar; 20(1):27-42. PMID: 29628515.
      Citations: 2     Fields:    Translation:HumansCells
    22. Zaki M, Thoenes M, Kawalia A, Nürnberg P, Kaiser R, Heller R, Bolz HJ. Recurrent and Prolonged Infections in a Child with a Homozygous IFIH1 Nonsense Mutation. Front Genet. 2017; 8:130. PMID: 29018476.
      Citations: 12     
    23. Gottfried M, Bennouna J, Bondarenko I, Douillard JY, Heigener DF, Krzakowski M, Mellemgaard A, Novello S, Orlov S, Summers Y, von Pawel J, Stöhr J, Kaiser R, Reck M. Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study. Target Oncol. 2017 08; 12(4):475-485. PMID: 28702806.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    24. Gilles R, Herling M, Holtick U, Heger E, Awerkiew S, Fish I, Höller K, Sierra S, Knops E, Kaiser R, Scheid C, Di Cristanziano V. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation. Med Microbiol Immunol. 2017 Oct; 206(5):355-362. PMID: 28702856.
      Citations: 13     Fields:    Translation:HumansCells
    25. Heger E, Kaiser R, Knops E, Neumann-Fraune M, Schuelter E, Pironti A, Lengauer T, Walter H, Sierra S. Results of the first international HIV-1 coreceptor proficiency panel test. J Clin Virol. 2017 08; 93:53-56. PMID: 28633097.
      Citations: 2     Fields:    Translation:HumansCells
    26. Walker A, Filke S, Lübke N, Obermeier M, Kaiser R, Häussinger D, Timm J, Bock HH. Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure. Virol J. 2017 06 08; 14(1):106. PMID: 28595606.
      Citations: 4     Fields:    Translation:Humans
    27. Höller K, Fabeni L, Herling M, Holtick U, Scheid C, Knops E, Lübke N, Kaiser R, Pfister H, Di Cristanziano V. Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2017 Aug; 99(2):133-140. PMID: 28401591.
      Citations: 4     Fields:    Translation:HumansCells
    28. Pironti A, Walter H, Pfeifer N, Knops E, Lübke N, Büch J, Di Giambenedetto S, Kaiser R, Lengauer T. Determination of Phenotypic Resistance Cutoffs From Routine Clinical Data. J Acquir Immune Defic Syndr. 2017 04 15; 74(5):e129-e137. PMID: 27787339.
      Citations: 2     Translation:HumansCells
    29. Gaschler-Markefski B, Sikken P, Heymach JV, Gottfried M, Mellemgaard A, Novello S, Gann CN, Barrueco J, Reck M, Hanna NH, Kaiser R. Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer. ESMO Open. 2017; 2(1):e000102. PMID: 28761724.
      Citations: 2     
    30. Walker A, Bergmann M, Camdereli J, Kaiser R, Lübke N, Timm J. A genotype independent, full-genome reverse-transcription protocol for HCV genotyping and resistance testing. J Clin Virol. 2017 06; 91:42-48. PMID: 28463753.
      Citations: 2     Fields:    Translation:HumansCells
    31. Pironti A, Pfeifer N, Walter H, Jensen BO, Zazzi M, Gomes P, Kaiser R, Lengauer T. Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool. PLoS One. 2017; 12(4):e0174992. PMID: 28394945.
      Citations: 3     Fields:    Translation:HumansCells
    32. Böttcher S, Obermeier PE, Diedrich S, Kaboré Y, D'Alfonso R, Pfister H, Kaiser R, Di Cristanziano V. Genome Sequence of Novel Human Parechovirus Type 17. Genome Announc. 2017 Feb 23; 5(8). PMID: 28232443.
      Citations: 1     
    33. Döring M, Borrego P, Büch J, Martins A, Friedrich G, Camacho RJ, Eberle J, Kaiser R, Lengauer T, Taveira N, Pfeifer N. A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support. Retrovirology. 2016 Dec 20; 13(1):85. PMID: 27998283.
      Citations: 2     Fields:    Translation:HumansCells
    34. Demir M, Phiri S, Kaiser R, Chaweza T, Neuhann F, Tweya H, Fätkenheuer G, Steffen HM. HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi. Emerg Infect Dis. 2016 11; 22(11):2018-2020. PMID: 27767917.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    35. Dallinger C, Trommeshauser D, Marzin K, Liesener A, Kaiser R, Stopfer P. Pharmacokinetic Properties of Nintedanib in Healthy Volunteers and Patients With Advanced Cancer. J Clin Pharmacol. 2016 11; 56(11):1387-1394. PMID: 27093880.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    36. Hanna NH, Kaiser R, Sullivan RN, Aren OR, Ahn MJ, Tiangco B, Voccia I, Pawel JV, Kovcin V, Agulnik J, Gaschler-Markefski B, Barrueco J, Sikken P, Schloss C, Kim JH. Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial. Lung Cancer. 2016 12; 102:65-73. PMID: 27987591.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    37. Heger E, Theis AA, Remmel K, Walter H, Pironti A, Knops E, Di Cristanziano V, Jensen B, Esser S, Kaiser R, Lübke N. Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors. J Virol Methods. 2016 12; 238:29-37. PMID: 27737783.
      Citations:    Fields:    Translation:HumansCells
    38. Knops E, Schübel N, Heger E, Neumann-Fraune M, Kaiser R, Inden S, Kalaghatgi P, Sierra S. HCV Resistance Profile Evolution in a GT1b, DAA-Naive Patient Before, On, and After Failing Triple DAA Therapy. Clin Gastroenterol Hepatol. 2017 02; 15(2):307-309. PMID: 27670383.
      Citations:    Fields:    Translation:HumansCells
    39. Walker A, Kaiser R, Bartenschlager R, Timm J. Genotypic resistance testing of HCV - is there a clinical need? GMS Infect Dis. 2016; 4:Doc05. PMID: 30671319.
      Citations:    
    40. Kartashev V, Döring M, Nieto L, Coletta E, Kaiser R, Sierra S. New findings in HCV genotype distribution in selected West European, Russian and Israeli regions. J Clin Virol. 2016 08; 81:82-9. PMID: 27367545.
      Citations: 20     Fields:    Translation:HumansCells
    41. Kalaghatgi P, Sikorski AM, Knops E, Rupp D, Sierra S, Heger E, Neumann-Fraune M, Beggel B, Walker A, Timm J, Walter H, Obermeier M, Kaiser R, Bartenschlager R, Lengauer T. Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents. PLoS One. 2016; 11(5):e0155869. PMID: 27196673.
      Citations: 31     Fields:    Translation:HumansCells
    42. Riemenschneider M, Cashin KY, Budeus B, Sierra S, Shirvani-Dastgerdi E, Bayanolhagh S, Kaiser R, Gorry PR, Heider D. Genotypic Prediction of Co-receptor Tropism of HIV-1 Subtypes A and C. Sci Rep. 2016 04 29; 6:24883. PMID: 27126912.
      Citations: 10     Fields:    Translation:HumansCells
    43. Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S. Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study. Clin Infect Dis. 2016 07 01; 63(1):122-32. PMID: 27048747.
      Citations: 7     Fields:    Translation:Humans
    44. Herling M, Schröder L, Awerkiew S, Chakupurakal G, Holtick U, Kaiser R, Pfister H, Scheid C, Di Cristanziano V. Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity. J Clin Virol. 2016 Jan; 74:57-60. PMID: 26672492.
      Citations: 5     Fields:    Translation:HumansCells
    45. Daga H, Takeda K, Okada H, Miyazaki M, Ueda S, Kaneda H, Okamoto I, Yoh K, Goto K, Konishi K, Sarashina A, Tanaka T, Kaiser R, Nakagawa K. Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2015 Dec; 76(6):1225-33. PMID: 26560486.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    46. Di Cristanziano V, Böttcher S, Diedrich S, Timmen-Wego M, Knops E, Lübke N, Kaiser R, Pfister H, Kaboré Y, D'Alfonso R. Erratum to "Detection and characterization of enteroviruses and parechoviruses in healthy people living in the South of Côte d'Ivoire" [J. Clin. Virol. 71 (2015) 40-43]. J Clin Virol. 2015 Nov; 72:153. PMID: 26832940.
      Citations: 1     Fields:    
    47. Rabenau HF, Bannert N, Berger A, Donoso Mantke O, Eberle J, Enders M, Fickenscher H, Grunert HP, Gürtler L, Heim A, Huzly D, Kaiser R, Korn K, Nick S, Kücherer C, Nübling M, Obermeier M, Panning M, Zeichhardt H. [Not Available]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Sep; 58(9):1025. PMID: 26275568.
      Citations: 1     Fields:    
    48. Hinz B, Jauch O, Noky T, Friesecke S, Abel P, Kaiser R. CytoSorb, a novel therapeutic approach for patients with septic shock: a case report. Int J Artif Organs. 2015 Aug; 38(8):461-4. PMID: 26349530.
      Citations: 15     Fields:    Translation:Humans
    49. Di Cristanziano V, Timmen-Wego M, Lübke N, Kaiser R, Pfister H, Di Cave D, Berrilli F, Kaboré Y, D'Alfonso R. Application of Luminex Gastrointestinal Pathogen Panel to human stool samples from Côte d'Ivoire. J Infect Dev Ctries. 2015 08 29; 9(8):884-9. PMID: 26322882.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    50. Reck M, Mellemgaard A, von Pawel J, Gottfried M, Bondarenko I, Cheng Y, Zarogoulidis K, Luft A, Bennouna J, Barrueco J, Aboshady H, Hocke J, Kaiser R, Douillard JY. Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel. Lung Cancer. 2015 Nov; 90(2):267-73. PMID: 26415992.
      Citations: 11     Fields:    Translation:Humans
    51. Cristanziano VD, Veronica DC, Böttcher S, Sindy B, Diedrich S, Sabine D, Timmen-Wego M, Monika TW, Knops E, Elena K, Lübke N, Nadine L, Kaiser R, Rolf K, Pfister H, Herbert P, Kaboré Y, Yolande K, D'Alfonso R, Rossella D. Detection and characterization of enteroviruses and parechoviruses in healthy people living in the South of Côte d'Ivoire. J Clin Virol. 2015 Oct; 71:40-3. PMID: 26370313.
      Citations: 13     Fields:    Translation:HumansCells
    52. Charpentier C, Camacho R, Ruelle J, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Kaiser R, Descamps D, Obermeier M. HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update. Clin Infect Dis. 2015 Oct 15; 61(8):1346-7. PMID: 26187019.
      Citations: 8     Fields:    Translation:HumansCells
    53. Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Lepej SZ, Perno C, Boucher CA, Wensing AM. Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE). J Infect Dis. 2016 Jan 01; 213(1):39-48. PMID: 26136470.
      Citations: 8     Fields:    Translation:HumansCells
    54. Lübke N, Di Cristanziano V, Sierra S, Knops E, Schülter E, Jensen B, Oette M, Lengauer T, Kaiser R. Proviral DNA as a Target for HIV-1 Resistance Analysis. Intervirology. 2015; 58(3):184-9. PMID: 26139571.
      Citations: 5     Fields:    Translation:HumansCells
    55. Köksal MO, Beka H, Lübke N, Verheyen J, Eraksoy H, Cagatay A, Kaiser R, Akgül B, Agacfidan A. HIV-1 subtypes and drug resistance profiles in a cohort of heterosexual patients in Istanbul, Turkey. Med Microbiol Immunol. 2015 Aug; 204(4):551-5. PMID: 25916350.
      Citations: 2     Fields:    Translation:Cells
    56. Pironti A, Sierra S, Kaiser R, Lengauer T, Pfeifer N. Effects of sequence alterations on results from genotypic tropism testing. J Clin Virol. 2015 Apr; 65:68-73. PMID: 25766992.
      Citations:    Fields:    Translation:Cells
    57. Okamoto I, Miyazaki M, Takeda M, Terashima M, Azuma K, Hayashi H, Kaneda H, Kurata T, Tsurutani J, Seto T, Hirai F, Konishi K, Sarashina A, Yagi N, Kaiser R, Nakagawa K. Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. J Thorac Oncol. 2015 Feb; 10(2):346-52. PMID: 25299232.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    58. Roth GJ, Binder R, Colbatzky F, Dallinger C, Schlenker-Herceg R, Hilberg F, Wollin SL, Kaiser R. Nintedanib: from discovery to the clinic. J Med Chem. 2015 Feb 12; 58(3):1053-63. PMID: 25474320.
      Citations: 50     Fields:    Translation:HumansAnimals
    59. Geipel A, Seiz PL, Niekamp H, Neumann-Fraune M, Zhang K, Kaiser R, Protzer U, Gerlich WH, Glebe D. Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine. Antivir Ther. 2015; 20(8):779-87. PMID: 25560463.
      Citations: 5     Fields:    Translation:HumansCells
    60. Pilatz A, Hossain H, Kaiser R, Mankertz A, Schüttler CG, Domann E, Schuppe HC, Chakraborty T, Weidner W, Wagenlehner F. Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations. Eur Urol. 2015 Sep; 68(3):428-35. PMID: 25542628.
      Citations: 28     Fields:    Translation:HumansCells
    61. Novello S, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Barrueco J, Gaschler-Markefski B, Griebsch I, Palmer M, Reck M. Analysis of patient-reported outcomes from the LUME-Lung 1 trial: a randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer. Eur J Cancer. 2015 Feb; 51(3):317-26. PMID: 25534294.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    62. Edwards S, Stucki H, Bader J, Vidal V, Kaiser R, Battegay M, Klimkait T. A diagnostic HIV-1 tropism system based on sequence relatedness. J Clin Microbiol. 2015 Feb; 53(2):597-610. PMID: 25502529.
      Citations: 2     Fields:    Translation:HumansCells
    63. Popat S, Mellemgaard A, Fahrbach K, Martin A, Rizzo M, Kaiser R, Griebsch I, Reck M. Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis. Future Oncol. 2015; 11(3):409-20. PMID: 25478720.
      Citations: 16     Fields:    Translation:Humans
    64. Schülter E, Kaiser R, Zazzi M, Sönnerborg A, Camacho R, Verheyen J. Time on drug analysis based on real life data. J Int AIDS Soc. 2014; 17(4 Suppl 3):19790. PMID: 25397534.
      Citations:    Fields:    
    65. Pironti A, Pfeifer N, Kaiser R, Walter H, Lengauer T. Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences. J Int AIDS Soc. 2014; 17(4 Suppl 3):19743. PMID: 25397488.
      Citations: 1     Fields:    
    66. Schweitzer F, Mikkola V, Timmen-Wego M, Jensen B, Fätkenheuer G, Kaiser R. Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load. J Int AIDS Soc. 2014; 17(4 Suppl 3):19669. PMID: 25397419.
      Citations: 1     Fields:    
    67. Droz JP, Medioni J, Chevreau C, De Mont-Serrat H, Merger M, Stopfer P, Kaiser R, Oudard S. Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel. Anticancer Drugs. 2014 Oct; 25(9):1081-8. PMID: 24849708.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    68. Neogi U, Rao SD, Bontell I, Verheyen J, Rao VR, Gore SC, Soni N, Shet A, Schülter E, Ekstrand ML, Wondwossen A, Kaiser R, Madhusudhan MS, Prasad VR, Sonnerborg A. Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients. AIDS. 2014 Sep 24; 28(15):2319-22. PMID: 25102091.
      Citations: 11     Fields:    Translation:HumansCells
    69. Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R, Schadendorf D, Dittmer U, Esser S. Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. N Engl J Med. 2014 Aug 28; 371(9):880-2. PMID: 25162903.
      Citations: 65     Fields:    Translation:HumansCells
    70. Neumann-Fraune M, Beggel B, Kaiser R, Obermeier M. Hepatitis B virus drug resistance tools: one sequence, two predictions. Intervirology. 2014; 57(3-4):232-6. PMID: 25034493.
      Citations: 10     Fields:    Translation:HumansCells
    71. Mross K, Büchert M, Frost A, Medinger M, Stopfer P, Studeny M, Kaiser R. Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. BMC Cancer. 2014 Jul 11; 14:510. PMID: 25012508.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    72. Yoldas O, Agaçfidan A, Lübke N, Somer A, Hançerli S, Verheyen J, Kaiser R, Akgül B. Determination of drug resistance and virus typology in HIV-1-positive pediatric patients in Istanbul, Turkey. Intervirology. 2014; 57(5):297-9. PMID: 24992950.
      Citations: 1     Fields:    Translation:HumansCells
    73. Agacfidan A, Kaiser R, Akgül B. HIV in Turkey, a country bridging the Islamic world and Europe. J Infect Public Health. 2014 May-Jun; 7(3):249-50. PMID: 24598080.
      Citations: 1     Fields:    Translation:Humans
    74. Lengauer T, Pfeifer N, Kaiser R. Personalized HIV therapy to control drug resistance. Drug Discov Today Technol. 2014 Mar; 11:57-64. PMID: 24847654.
      Citations: 7     Fields:    Translation:Humans
    75. Reck M, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Gann CN, Barrueco J, Gaschler-Markefski B, Novello S. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol. 2014 Feb; 15(2):143-55. PMID: 24411639.
      Citations: 279     Fields:    Translation:HumansCTClinical Trials
    76. Beggel B, Neumann-Fraune M, Kaiser R, Verheyen J, Lengauer T. Inferring short-range linkage information from sequencing chromatograms. PLoS One. 2013; 8(12):e81687. PMID: 24376502.
      Citations: 1     Fields:    Translation:Cells
    77. Tu E, Swenson LC, Land S, Pett S, Emery S, Marks K, Kelleher AD, Kaye S, Kaiser R, Schuelter E, Harrigan R. Reply to "Issues on results of the external quality assessment for proviral DNA testing of HIV-1 Tropism in the Maraviroc Switch collaborative study". J Clin Microbiol. 2013 Dec; 51(12):4287. PMID: 24243995.
      Citations:    Fields:    Translation:HumansCells
    78. Oette M, Reuter S, Kaiser R, Jensen B, Lengauer T, Fätkenheuer G, Knechten H, Hower M, Sagir A, Pfister H, Häussinger D. Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort. Eur J Med Res. 2013 Nov 21; 18:48. PMID: 24262206.
      Citations:    Fields:    Translation:Humans
    79. Horwitz JA, Halper-Stromberg A, Mouquet H, Gitlin AD, Tretiakova A, Eisenreich TR, Malbec M, Gravemann S, Billerbeck E, Dorner M, Büning H, Schwartz O, Knops E, Kaiser R, Seaman MS, Wilson JM, Rice CM, Ploss A, Bjorkman PJ, Klein F, Nussenzweig MC. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A. 2013 Oct 08; 110(41):16538-43. PMID: 24043801.
      Citations: 143     Fields:    Translation:HumansAnimalsCells
    80. Libin P, Beheydt G, Deforche K, Imbrechts S, Ferreira F, Van Laethem K, Theys K, Carvalho AP, Cavaco-Silva J, Lapadula G, Torti C, Assel M, Wesner S, Snoeck J, Ruelle J, De Bel A, Lacor P, De Munter P, Van Wijngaerden E, Zazzi M, Kaiser R, Ayouba A, Peeters M, de Oliveira T, Alcantara LC, Grossman Z, Sloot P, Otelea D, Paraschiv S, Boucher C, Camacho RJ, Vandamme AM. RegaDB: community-driven data management and analysis for infectious diseases. Bioinformatics. 2013 Jun 01; 29(11):1477-80. PMID: 23645815.
      Citations: 14     Fields:    Translation:Humans
    81. Tu E, Swenson LC, Land S, Pett S, Emery S, Marks K, Kelleher AD, Kaye S, Kaiser R, Schuelter E, Harrigan R. Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study. J Clin Microbiol. 2013 Jul; 51(7):2063-71. PMID: 23596247.
      Citations: 5     Fields:    Translation:HumansCells
    82. Vercauteren J, Beheydt G, Prosperi M, Libin P, Imbrechts S, Camacho R, Clotet B, De Luca A, Grossman Z, Kaiser R, Sönnerborg A, Torti C, Van Wijngaerden E, Schmit JC, Zazzi M, Geretti AM, Vandamme AM, Van Laethem K. Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response. PLoS One. 2013; 8(4):e61436. PMID: 23613852.
      Citations: 6     Fields:    Translation:HumansCells
    83. Bozek K, Lengauer T, Sierra S, Kaiser R, Domingues FS. Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage. PLoS Comput Biol. 2013; 9(3):e1002977. PMID: 23555214.
      Citations: 12     Fields:    Translation:HumansCells
    84. Charpentier C, Camacho R, Ruelle J, Kaiser R, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Descamps D, Obermeier M. HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe. Clin Infect Dis. 2013 Jun; 56(11):1654-8. PMID: 23429380.
      Citations: 12     Fields:    Translation:HumansCells
    85. Neumann-Fraune M, Beggel B, Pfister H, Kaiser R, Verheyen J. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates. J Med Virol. 2013 May; 85(5):775-9. PMID: 23408582.
      Citations: 4     Fields:    Translation:HumansCells
    86. De Luca A, Dunn D, Zazzi M, Camacho R, Torti C, Fanti I, Kaiser R, Sönnerborg A, Codoñer FM, Van Laethem K, Vandamme AM, Bansi L, Ghisetti V, van de Vijver DA, Asboe D, Prosperi MC, Di Giambenedetto S. Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. J Infect Dis. 2013 Apr 15; 207(8):1216-20. PMID: 23315324.
      Citations: 17     Fields:    Translation:HumansCells
    87. Alpsar D, Agacfidan A, Lübke N, Verheyen J, Eraksoy H, Cagatay A, Bozkaya E, Kaiser R, Akgül B. Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul. Med Microbiol Immunol. 2013 Jun; 202(3):251-5. PMID: 23296905.
      Citations: 4     Fields:    Translation:HumansCells
    88. Kaiser R, Wensing AM. HIV co-receptor tropism: old target for new therapeutic strategies. Curr Opin HIV AIDS. 2012 Sep; 7(5):429-31. PMID: 22789988.
      Citations:    Fields:    Translation:HumansCells
    89. Bozek K, Eckhardt M, Sierra S, Anders M, Kaiser R, Kräusslich HG, Müller B, Lengauer T. An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data. Retrovirology. 2012 Jul 25; 9:60. PMID: 22830600.
      Citations: 8     Fields:    Translation:HumansCells
    90. Verheyen J, Neumann-Fraune M, Berg T, Kaiser R, Obermeier M. The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays. J Clin Virol. 2012 Jul; 54(3):279-81. PMID: 22595307.
      Citations: 11     Fields:    Translation:HumansCells
    91. Rhee SY, Blanco JL, Liu TF, Pere I, Kaiser R, Zazzi M, Incardona F, Towner W, Gatell JM, De Luca A, Fessel WJ, Shafer RW. Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes. AIDS Res Ther. 2012 May 03; 9(1):13. PMID: 22554313.
      Citations: 2     Fields:    
    92. Verheyen J, Kaiser R, Bozic M, Timmen-Wego M, Maier BK, Kessler HH. Extraction of viral nucleic acids: comparison of five automated nucleic acid extraction platforms. J Clin Virol. 2012 Jul; 54(3):255-9. PMID: 22503856.
      Citations: 20     Fields:    Translation:HumansCells
    93. Obermeier M, Pironti A, Berg T, Braun P, Däumer M, Eberle J, Ehret R, Kaiser R, Kleinkauf N, Korn K, Kücherer C, Müller H, Noah C, Stürmer M, Thielen A, Wolf E, Walter H. HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge. Intervirology. 2012; 55(2):102-7. PMID: 22286877.
      Citations: 14     Fields:    Translation:HumansCells
    94. Zazzi M, Incardona F, Rosen-Zvi M, Prosperi M, Lengauer T, Altmann A, Sonnerborg A, Lavee T, Schülter E, Kaiser R. Predicting response to antiretroviral treatment by machine learning: the EuResist project. Intervirology. 2012; 55(2):123-7. PMID: 22286881.
      Citations: 14     Fields:    Translation:HumansCells
    95. Reuter S, Oette M, Kaiser R, Lengauer T, Fätkenheuer G, Rockstroh JK, Knechten H, Häussinger D. Risk factors associated with older age in treatment-naive HIV-positive patients. Intervirology. 2012; 55(2):147-53. PMID: 22286885.
      Citations: 4     Fields:    Translation:Humans
    96. Oette M, Reuter S, Kaiser R, Lengauer T, Fätkenheuer G, Knechten H, Hower M, Pfister H, Häussinger D. Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009. Intervirology. 2012; 55(2):154-9. PMID: 22286886.
      Citations: 8     Fields:    Translation:HumansCells
    97. Oette M, Schülter E, Rosen-Zvi M, Peres Y, Zazzi M, Sönnerborg A, Struck D, Altmann A, Kaiser R. Efficacy of antiretroviral therapy switch in HIV-infected patients: a 10-year analysis of the EuResist Cohort. Intervirology. 2012; 55(2):160-6. PMID: 22286887.
      Citations: 2     Fields:    Translation:Humans
    98. Jensen B, Esser S, Kaiser R, Luebke N, Häussinger D. How individual can personalized antiretroviral treatment be? Deep salvage in an HIV-1-infected patient. Intervirology. 2012; 55(2):167-71. PMID: 22286888.
      Citations:    Fields:    Translation:HumansCells
    99. Lawyer G, Schülter E, Kaiser R, Reuter S, Oette M, Lengauer T. Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohort. Med Microbiol Immunol. 2012 Aug; 201(3):259-69. PMID: 22262052.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    100. Knops E, Brakier-Gingras L, Schülter E, Pfister H, Kaiser R, Verheyen J. Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitors. Med Microbiol Immunol. 2012 May; 201(2):213-8. PMID: 22200908.
      Citations: 11     Fields:    Translation:HumansCells
    101. Sierra S, Kaiser R, Lübke N, Thielen A, Schuelter E, Heger E, Däumer M, Reuter S, Esser S, Fätkenheuer G, Pfister H, Oette M, Lengauer T. Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach. J Vis Exp. 2011 Dec 01; (58). PMID: 22157596.
      Citations: 7     Fields:    Translation:HumansCells
    102. Körner RW, Söderlund-Venermo M, van Koningsbruggen-Rietschel S, Kaiser R, Malecki M, Schildgen O. Severe human bocavirus infection, Germany. Emerg Infect Dis. 2011 Dec; 17(12):2303-5. PMID: 22172367.
      Citations: 30     Fields:    Translation:HumansCells
    103. Prosperi MC, Mackie N, Di Giambenedetto S, Zazzi M, Camacho R, Fanti I, Torti C, Sönnerborg A, Kaiser R, Codoñer FM, Van Laethem K, Bansi L, van de Vijver DA, Geretti AM, De Luca A. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study. J Antimicrob Chemother. 2011 Aug; 66(8):1886-96. PMID: 21624929.
      Citations: 16     Fields:    Translation:HumansCells
    104. Heger E, Thielen A, Gilles R, Obermeier M, Lengauer T, Kaiser R, Trapp S. APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1. Med Microbiol Immunol. 2012 Feb; 201(1):7-16. PMID: 21573951.
      Citations: 8     Fields:    Translation:HumansCells
    105. Däumer M, Kaiser R, Klein R, Lengauer T, Thiele B, Thielen A. Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis. BMC Med Inform Decis Mak. 2011 May 13; 11:30. PMID: 21569501.
      Citations: 10     Fields:    Translation:HumansCells
    106. Sierra S, Lübke N, Walter H, Schülter E, Reuter S, Fätkenheuer G, Bickel M, da Silva H, Kaiser R, Esser S. The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes. Med Microbiol Immunol. 2011 Nov; 200(4):225-32. PMID: 21475993.
      Citations: 6     Fields:    Translation:HumansCells
    107. Schülter E, Oette M, Balduin M, Reuter S, Rockstroh J, Fätkenheuer G, Esser S, Lengauer T, Agacfidan A, Pfister H, Kaiser R, Akgül B. HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany. Med Microbiol Immunol. 2011 Nov; 200(4):219-23. PMID: 21461764.
      Citations: 8     Fields:    Translation:HumansCells
    108. Song X, Varker H, Eichelbaum M, Stopfer P, Shahidi M, Wilson K, Kaiser R, Finnern HW. Treatment of lung cancer patients and concomitant use of drugs interacting with cytochrome P450 isoenzymes. Lung Cancer. 2011 Oct; 74(1):103-11. PMID: 21382644.
      Citations: 5     Fields:    Translation:Humans
    109. Wiesmann F, Vachta J, Ehret R, Walter H, Kaiser R, Stürmer M, Tappe A, Däumer M, Berg T, Naeth G, Braun P, Knechten H. The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage? AIDS Res Ther. 2011 Feb 13; 8:7. PMID: 21314993.
      Citations: 8     Fields:    
    110. Mueller SM, Spriewald BM, Bergmann S, Eismann K, Leykauf M, Korn K, Walter H, Schmidt B, Arnold ML, Harrer EG, Kaiser R, Schweitzer F, Braun P, Reuter S, Jaeger H, Wolf E, Brockmeyer NH, Jansen K, Michalik C, Harrer T. Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition. J Acquir Immune Defic Syndr. 2011 Feb 01; 56(2):109-17. PMID: 21107269.
      Citations: 5     Translation:HumansCells
    111. Reuter S, Oette M, Sichtig N, Kaiser R, Balduin M, Jensen B, Häussinger D. Changes in the HIV-1 mutational profile before first-line HAART in the RESINA cohort. J Med Virol. 2011 Feb; 83(2):187-95. PMID: 21181911.
      Citations: 2     Fields:    Translation:HumansCells
    112. Stopfer P, Rathgen K, Bischoff D, Lüdtke S, Marzin K, Kaiser R, Wagner K, Ebner T. Pharmacokinetics and metabolism of BIBF 1120 after oral dosing to healthy male volunteers. Xenobiotica. 2011 Apr; 41(4):297-311. PMID: 21204634.
      Citations: 24     Fields:    Translation:Humans
    113. Metzner KJ, Rauch P, Braun P, Knechten H, Ehret R, Korn K, Kaiser R, Sichtig N, Ranneberg B, van Lunzen J, Walter H. Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients. J Clin Virol. 2011 Feb; 50(2):156-61. PMID: 21056001.
      Citations: 26     Fields:    Translation:HumansCells
    114. Thielen A, Sichtig N, Kaiser R, Lam J, Harrigan PR, Lengauer T. Improved prediction of HIV-1 coreceptor usage with sequence information from the second hypervariable loop of gp120. J Infect Dis. 2010 Nov 01; 202(9):1435-43. PMID: 20874088.
      Citations: 15     Fields:    Translation:HumansCells
    115. Prosperi MC, Rosen-Zvi M, Altmann A, Zazzi M, Di Giambenedetto S, Kaiser R, Schülter E, Struck D, Sloot P, van de Vijver DA, Vandamme AM, Sönnerborg A. Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models. PLoS One. 2010 Oct 29; 5(10):e13753. PMID: 21060792.
      Citations: 7     Fields:    Translation:HumansCells
    116. Däumer MP, Schneider B, Giesen DM, Aziz S, Kaiser R, Kupfer B, Schneweis KE, Schneider-Mergener J, Reineke U, Matz B, Eis-Hübinger AM. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity. Med Microbiol Immunol. 2011 May; 200(2):85-97. PMID: 20931340.
      Citations: 8     Fields:    Translation:AnimalsCells
    117. Rhee SY, Margeridon-Thermet S, Nguyen MH, Liu TF, Kagan RM, Beggel B, Verheyen J, Kaiser R, Shafer RW. Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery. Antiviral Res. 2010 Dec; 88(3):269-75. PMID: 20875460.
      Citations: 20     Fields:    Translation:HumansCells
    118. Reuter S, Oette M, Wilhelm FC, Beggel B, Kaiser R, Balduin M, Schweitzer F, Verheyen J, Adams O, Lengauer T, Fätkenheuer G, Pfister H, Häussinger D. Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients. Med Microbiol Immunol. 2011 Feb; 200(1):39-49. PMID: 20853118.
      Citations: 15     Fields:    Translation:Humans
    119. Okamoto I, Kaneda H, Satoh T, Okamoto W, Miyazaki M, Morinaga R, Ueda S, Terashima M, Tsuya A, Sarashina A, Konishi K, Arao T, Nishio K, Kaiser R, Nakagawa K. Phase I safety, pharmacokinetic, and biomarker study of BIBF 1120, an oral triple tyrosine kinase inhibitor in patients with advanced solid tumors. Mol Cancer Ther. 2010 Oct; 9(10):2825-33. PMID: 20688946.
      Citations: 35     Translation:HumansCTClinical Trials
    120. Ellis PM, Kaiser R, Zhao Y, Stopfer P, Gyorffy S, Hanna N. Phase I open-label study of continuous treatment with BIBF 1120, a triple angiokinase inhibitor, and pemetrexed in pretreated non-small cell lung cancer patients. Clin Cancer Res. 2010 May 15; 16(10):2881-9. PMID: 20460487.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    121. Knops E, Däumer M, Awerkiew S, Kartashev V, Schülter E, Kutsev S, Brakier-Gingras L, Kaiser R, Pfister H, Verheyen J. Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates. J Antimicrob Chemother. 2010 Jul; 65(7):1472-6. PMID: 20430786.
      Citations: 6     Fields:    Translation:HumansCells
    122. Knops E, Kemper I, Schülter E, Pfister H, Kaiser R, Verheyen J. The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V. AIDS. 2010 Mar 13; 24(5):779-81. PMID: 20139751.
      Citations: 6     Fields:    Translation:HumansCells
    123. Verheyen J, Verhofstede C, Knops E, Vandekerckhove L, Fun A, Brunen D, Dauwe K, Wensing AM, Pfister H, Kaiser R, Nijhuis M. High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates. AIDS. 2010 Mar 13; 24(5):669-73. PMID: 19926962.
      Citations: 18     Fields:    Translation:HumansCells
    124. Däumer M, Awerkiew S, Aragón SS, Kartashev V, Poplavskaja T, Klein R, Sichtig N, Thiele B, Lengauer T, Roomp K, Pfister H, Kaiser R. Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source. AIDS Res Hum Retroviruses. 2010 Mar; 26(3):275-8. PMID: 20334563.
      Citations: 2     Fields:    Translation:HumansCells
    125. Weisser H, Altmann A, Sierra S, Incardona F, Struck D, Sönnerborg A, Kaiser R, Zazzi M, Tschochner M, Walter H, Lengauer T. Only slight impact of predicted replicative capacity for therapy response prediction. PLoS One. 2010 Feb 03; 5(2):e9044. PMID: 20140263.
      Citations: 1     Fields:    Translation:HumansCells
    126. Verheyen J, Schweitzer F, Harrer EG, Knops E, Mueller SM, Däumer M, Eismann K, Bergmann S, Spriewald BM, Kaiser R, Harrer T. Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates. Antivir Ther. 2010; 15(6):907-12. PMID: 20834103.
      Citations: 2     Fields:    Translation:HumansCells
    127. Mross K, Stefanic M, Gmehling D, Frost A, Baas F, Unger C, Strecker R, Henning J, Gaschler-Markefski B, Stopfer P, de Rossi L, Kaiser R. Phase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumors. Clin Cancer Res. 2010 Jan 01; 16(1):311-9. PMID: 20028771.
      Citations: 57     Fields:    Translation:HumansCTClinical Trials
    128. Soriano V, Perno CF, Kaiser R, Calvez V, Gatell JM, di Perri G, Pillay D, Rockstroh J, Geretti AM. When and how to use maraviroc in HIV-infected patients. AIDS. 2009 Nov 27; 23(18):2377-85. PMID: 19834318.
      Citations: 15     Fields:    Translation:HumansCells
    129. Bozek K, Thielen A, Sierra S, Kaiser R, Lengauer T. V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV. PLoS One. 2009 Oct 09; 4(10):e7387. PMID: 19816596.
      Citations: 5     Fields:    Translation:HumansCells
    130. Verheyen J, Balduin M, Kaiser R, Pfister H. Seasonal influenza virus species in patient swab samples analyzed for the presence of the pandemic (H1N1) 2009 influenza virus. J Clin Microbiol. 2009 Dec; 47(12):4187-8. PMID: 19794039.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    131. Gronewold TM, Baumgartner A, Hierer J, Sierra S, Blind M, Schäfer F, Blümer J, Tillmann T, Kiwitz A, Kaiser R, Zabe-Kühn M, Quandt E, Famulok M. Kinetic binding analysis of aptamers targeting HIV-1 proteins by a combination of a microbalance array and mass spectrometry (MAMS). J Proteome Res. 2009 Jul; 8(7):3568-77. PMID: 19469583.
      Citations: 4     Fields:    Translation:HumansCells
    132. Sichtig N, Sierra S, Kaiser R, Däumer M, Reuter S, Schülter E, Altmann A, Fätkenheuer G, Dittmer U, Pfister H, Esser S. Evolution of raltegravir resistance during therapy. J Antimicrob Chemother. 2009 Jul; 64(1):25-32. PMID: 19447792.
      Citations: 38     Fields:    Translation:HumansCells
    133. Sierra S, Lengauer T, Kaiser R. [Resistance screening]. MMW Fortschr Med. 2009 Apr 30; 151(18):72, 74-5. PMID: 19769083.
      Citations:    Fields:    Translation:HumansCells
    134. Balduin M, Oette M, Däumer MP, Hoffmann D, Pfister HJ, Kaiser R. Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure. J Clin Virol. 2009 May; 45(1):34-8. PMID: 19375978.
      Citations: 22     Fields:    Translation:HumansCells
    135. Altmann A, Däumer M, Beerenwinkel N, Peres Y, Schülter E, Büch J, Rhee SY, Sönnerborg A, Fessel WJ, Shafer RW, Zazzi M, Kaiser R, Lengauer T. Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database. J Infect Dis. 2009 Apr 01; 199(7):999-1006. PMID: 19239365.
      Citations: 17     Fields:    Translation:HumansCells
    136. Altmann A, Sing T, Vermeiren H, Winters B, Van Craenenbroeck E, Van der Borght K, Rhee SY, Shafer RW, Schülter E, Kaiser R, Peres Y, Sönnerborg A, Fessel WJ, Incardona F, Zazzi M, Bacheler L, Van Vlijmen H, Lengauer T. Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype. Antivir Ther. 2009; 14(2):273-83. PMID: 19430102.
      Citations: 5     Fields:    Translation:HumansCells
    137. Verheyen J, Knops E, Kupfer B, Hamouda O, Somogyi S, Schuldenzucker U, Hoffmann D, Kaiser R, Pfister H, Kücherer C. Prevalence of C-terminal gag cleavage site mutations in HIV from therapy-naïve patients. J Infect. 2009 Jan; 58(1):61-7. PMID: 19110315.
      Citations: 12     Fields:    Translation:HumansCells
    138. Mross K, Frost A, Steinbild S, Hedbom S, Rentschler J, Kaiser R, Rouyrre N, Trommeshauser D, Hoesl CE, Munzert G. Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors. J Clin Oncol. 2008 Dec 01; 26(34):5511-7. PMID: 18955456.
      Citations: 60     Fields:    Translation:HumansCellsCTClinical Trials
    139. Paar C, Palmetshofer C, Flieger K, Geit M, Kaiser R, Stekel H, Berg J. Genotypic antiretroviral resistance testing for human immunodeficiency virus type 1 integrase inhibitors by use of the TruGene sequencing system. J Clin Microbiol. 2008 Dec; 46(12):4087-90. PMID: 18945845.
      Citations: 4     Fields:    Translation:HumansCells
    140. Altmann A, Rosen-Zvi M, Prosperi M, Aharoni E, Neuvirth H, Schülter E, Büch J, Struck D, Peres Y, Incardona F, Sönnerborg A, Kaiser R, Zazzi M, Lengauer T. Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy. PLoS One. 2008; 3(10):e3470. PMID: 18941628.
      Citations: 15     Fields:    
    141. Rosen-Zvi M, Altmann A, Prosperi M, Aharoni E, Neuvirth H, Sönnerborg A, Schülter E, Struck D, Peres Y, Incardona F, Kaiser R, Zazzi M, Lengauer T. Selecting anti-HIV therapies based on a variety of genomic and clinical factors. Bioinformatics. 2008 Jul 01; 24(13):i399-406. PMID: 18586740.
      Citations: 13     Fields:    Translation:Humans
    142. Stamm TJ, Adli M, Kirchheiner J, Smolka MN, Kaiser R, Tremblay PB, Bauer M. Serotonin transporter gene and response to lithium augmentation in depression. Psychiatr Genet. 2008 Apr; 18(2):92-7. PMID: 18349701.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    143. Meineke C, Tzvetkov MV, Bokelmann K, Oetjen E, Hirsch-Ernst K, Kaiser R, Brockmöller J. Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene. Pharmacogenet Genomics. 2008 Mar; 18(3):219-30. PMID: 18300944.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    144. Lengauer T, Sander O, Sierra S, Thielen A, Kaiser R. Bioinformatics prediction of HIV coreceptor usage. Nat Biotechnol. 2007 Dec; 25(12):1407-10. PMID: 18066037.
      Citations: 133     Fields:    Translation:Cells
    145. Kupfer B, Sing T, Schüffler P, Hall R, Kurz R, McKeown A, Schneweis KE, Eberl W, Oldenburg J, Brackmann HH, Rockstroh JK, Spengler U, Däumer MP, Kaiser R, Lengauer T, Matz B. Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1. J Med Virol. 2007 Nov; 79(11):1629-39. PMID: 17854039.
      Citations: 5     Fields:    Translation:HumansCells
    146. Kupfer B, Matz B, Däumer MP, Roden F, Rockstroh JK, Qurishi N, Spengler U, Kaiser R. Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml. J Med Virol. 2007 Oct; 79(10):1440-5. PMID: 17705170.
      Citations: 7     Fields:    Translation:HumansCells
    147. Sagir A, Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Schmutz G, Hower M, Emmelkamp J, Pfister H, Häussinger D. Trends of prevalence of primary HIV drug resistance in Germany. J Antimicrob Chemother. 2007 Oct; 60(4):843-8. PMID: 17715124.
      Citations: 19     Fields:    Translation:HumansCells
    148. Ahlenstiel G, Roomp K, Däumer M, Nattermann J, Vogel M, Rockstroh JK, Beerenwinkel N, Kaiser R, Nischalke HD, Sauerbruch T, Lengauer T, Spengler U. Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level. Clin Vaccine Immunol. 2007 Oct; 14(10):1266-73. PMID: 17715334.
      Citations: 10     Fields:    Translation:HumansCells
    149. Kühne A, Kaiser R, Schirmer M, Heider U, Muhlke S, Niere W, Overbeck T, Hohloch K, Trümper L, Sezer O, Brockmöller J. Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan. Pharmacogenet Genomics. 2007 Jul; 17(7):505-17. PMID: 17558306.
      Citations: 16     Fields:    Translation:HumansCells
    150. Müller J, Eis-Hübinger AM, Däumer M, Kaiser R, Rox JM, Gürtler L, Hanfland P, Pötzsch B. A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region. J Virol Methods. 2007 Jun; 142(1-2):127-35. PMID: 17321607.
      Citations: 7     Fields:    Translation:HumansCells
    151. Altmann A, Beerenwinkel N, Sing T, Savenkov I, Doumer M, Kaiser R, Rhee SY, Fessel WJ, Shafer RW, Lengauer T. Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance. Antivir Ther. 2007; 12(2):169-78. PMID: 17503659.
      Citations: 18     Fields:    Translation:HumansCells
    152. Sing T, Low AJ, Beerenwinkel N, Sander O, Cheung PK, Domingues FS, Büch J, Däumer M, Kaiser R, Lengauer T, Harrigan PR. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther. 2007; 12(7):1097-106. PMID: 18018768.
      Citations: 78     Fields:    Translation:HumansCells
    153. Awerkiew S, Däumer M, Reiser M, Wend UC, Pfister H, Kaiser R, Willems WR, Gerlich WH. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol. 2007 Jan; 38(1):83-6. PMID: 17134939.
      Citations: 20     Fields:    Translation:HumansCells
    154. Mössner R, Anders N, König IR, Krüger U, Schmidt D, Berking C, Ziegler A, Brockmöller J, Kaiser R, Volkenandt M, Westphal GA, Reich K. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch Dermatol Res. 2007 Jan; 298(8):371-9. PMID: 17072629.
      Citations: 13     Fields:    Translation:Humans
    155. Ndjomou J, Zekeng L, Kaptue L, Däumer M, Kaiser R, Matz B, Kupfer B. Functional domains of the human immunodeficiency virus type 1 Nef protein are conserved among different clades in Cameroon. AIDS Res Hum Retroviruses. 2006 Oct; 22(10):936-44. PMID: 17067262.
      Citations: 1     Fields:    Translation:HumansCells
    156. Kupfer B, Vehreschild J, Cornely O, Kaiser R, Plum G, Viazov S, Franzen C, Tillmann RL, Simon A, Müller A, Schildgen O. Severe pneumonia and human bocavirus in adult. Emerg Infect Dis. 2006 Oct; 12(10):1614-6. PMID: 17176591.
      Citations: 40     Fields:    Translation:HumansCells
    157. Lehmann C, Däumer M, Boussaad I, Sing T, Beerenwinkel N, Lengauer T, Schmeisser N, Wyen C, Fätkenheuer G, Kaiser R. Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART. J Clin Virol. 2006 Dec; 37(4):300-4. PMID: 17005445.
      Citations: 12     Fields:    Translation:HumansCells
    158. Simon A, Groneck P, Kupfer B, Kaiser R, Plum G, Tillmann RL, Müller A, Schildgen O. Detection of bocavirus DNA in nasopharyngeal aspirates of a child with bronchiolitis. J Infect. 2007 Mar; 54(3):e125-7. PMID: 16968654.
      Citations: 15     Fields:    Translation:HumansCells
    159. Mössner R, Meyer P, Jankowski F, König IR, Krüger U, Kammerer S, Westphal G, Boettger MB, Berking C, Schmitt C, Brockmöller J, Ziegler A, Stapelmann H, Kaiser R, Volkenandt M, Reich K. Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk. Cancer Lett. 2007 Feb 08; 246(1-2):218-23. PMID: 16713673.
      Citations: 6     Fields:    Translation:Humans
    160. Oette M, Kaiser R, Däumer M, Petch R, Fätkenheuer G, Carls H, Rockstroh JK, Schmalöer D, Stechel J, Feldt T, Pfister H, Häussinger D. Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr. 2006 Apr 15; 41(5):573-81. PMID: 16652031.
      Citations: 29     Translation:Humans
    161. Cordes F, Kaiser R, Selbig J. Bioinformatics approach to predicting HIV drug resistance. Expert Rev Mol Diagn. 2006 Mar; 6(2):207-15. PMID: 16512780.
      Citations: 2     Fields:    Translation:HumansCells
    162. Verheyen J, Litau E, Sing T, Däumer M, Balduin M, Oette M, Fätkenheuer G, Rockstroh JK, Schuldenzucker U, Hoffmann D, Pfister H, Kaiser R. Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients. Antivir Ther. 2006; 11(7):879-87. PMID: 17302250.
      Citations: 31     Fields:    Translation:HumansCells
    163. Sierra S, Kupfer B, Kaiser R. Basics of the virology of HIV-1 and its replication. J Clin Virol. 2005 Dec; 34(4):233-44. PMID: 16198625.
      Citations: 26     Fields:    Translation:HumansCells
    164. Balduin M, Sierra S, Däumer MP, Rockstroh JK, Oette M, Fätkenheuer G, Kupfer B, Beerenwinkel N, Hoffmann D, Selbig J, Pfister HJ, Kaiser R. Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy. J Clin Virol. 2005 Dec; 34(4):277-87. PMID: 16191482.
      Citations: 4     Fields:    Translation:HumansCells
    165. Beerenwinkel N, Sing T, Lengauer T, Rahnenführer J, Roomp K, Savenkov I, Fischer R, Hoffmann D, Selbig J, Korn K, Walter H, Berg T, Braun P, Fätkenheuer G, Oette M, Rockstroh J, Kupfer B, Kaiser R, Däumer M. Computational methods for the design of effective therapies against drug resistant HIV strains. Bioinformatics. 2005 Nov 01; 21(21):3943-50. PMID: 16144807.
      Citations: 23     Fields:    Translation:Humans
    166. Kupfer B, Ruf T, Matz B, Nattermann J, Spengler U, Rockstroh JK, Brackmann HH, Blümel J, Tacke M, Kaiser R. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. J Clin Virol. 2005 Sep; 34(1):42-7. PMID: 16087123.
      Citations: 2     Fields:    Translation:HumansCells
    167. Kaiser R. Antiemetic guidelines: are they being used? Lancet Oncol. 2005 Aug; 6(8):622-5. PMID: 16054573.
      Citations: 17     Fields:    Translation:Humans
    168. Beerenwinkel N, Rahnenführer J, Däumer M, Hoffmann D, Kaiser R, Selbig J, Lengauer T. Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol. 2005 Jul-Aug; 12(6):584-98. PMID: 16108705.
      Citations: 36     Fields:    Translation:HumansCells
    169. Beerenwinkel N, Däumer M, Sing T, Rahnenfuhrer J, Lengauer T, Selbig J, Hoffmann D, Kaiser R. Estimating HIV evolutionary pathways and the genetic barrier to drug resistance. J Infect Dis. 2005 Jun 01; 191(11):1953-60. PMID: 15871130.
      Citations: 20     Fields:    Translation:Cells
    170. Beerenwinkel N, Rahnenführer J, Kaiser R, Hoffmann D, Selbig J, Lengauer T. Mtreemix: a software package for learning and using mixture models of mutagenetic trees. Bioinformatics. 2005 May 01; 21(9):2106-7. PMID: 15657098.
      Citations: 25     Fields:    
    171. Schildgen O, Schewe CK, Vogel M, Däumer M, Kaiser R, Weitner L, Matz B, Rockstroh JK. Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment. AIDS. 2004 Nov 19; 18(17):2325-7. PMID: 15577546.
      Citations: 8     Fields:    Translation:HumansCells
    172. Roots I, Gerloff T, Meisel C, Kirchheiner J, Goldammer M, Kaiser R, Laschinski G, Brockmöller J, Cascorbi I, Kleeberg U, Hildebrandt AG. Pharmacogenetics-based new therapeutic concepts. Drug Metab Rev. 2004 Oct; 36(3-4):617-38. PMID: 15554239.
      Citations: 4     Fields:    Translation:HumansAnimals
    173. Kaiser R, Tremblay PB, Sezer O, Possinger K, Roots I, Brockmöller J. Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists. Pharmacogenetics. 2004 May; 14(5):271-8. PMID: 15115912.
      Citations: 20     Fields:    Translation:Humans
    174. Mössner R, Kaiser R, Matern P, Krüger U, Westphal GA, Brockmöller J, Ziegler A, Neumann C, König IR, Reich K. Variations in the genes encoding the peroxisome proliferator-activated receptors alpha and gamma in psoriasis. Arch Dermatol Res. 2004 Jun; 296(1):1-5. PMID: 15083308.
      Citations: 3     Fields:    Translation:Humans
    175. Jönsson EG, Kaiser R, Brockmöller J, Nimgaonkar VL, Crocq MA. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr Genet. 2004 Mar; 14(1):9-12. PMID: 15091310.
      Citations: 15     Fields:    Translation:Humans
    176. Wolf K, Walter H, Beerenwinkel N, Keulen W, Kaiser R, Hoffmann D, Lengauer T, Selbig J, Vandamme AM, Korn K, Schmidt B. Tenofovir resistance and resensitization. Antimicrob Agents Chemother. 2003 Nov; 47(11):3478-84. PMID: 14576105.
      Citations: 25     Fields:    Translation:HumansCells
    177. Beerenwinkel N, Däumer M, Oette M, Korn K, Hoffmann D, Kaiser R, Lengauer T, Selbig J, Walter H. Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res. 2003 Jul 01; 31(13):3850-5. PMID: 12824435.
      Citations: 72     Fields:    Translation:HumansCells
    178. Tremblay PB, Kaiser R, Sezer O, Rosler N, Schelenz C, Possinger K, Roots I, Brockmoller J. Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J Clin Oncol. 2003 Jun 01; 21(11):2147-55. PMID: 12775740.
      Citations: 44     Fields:    Translation:Humans
    179. Beerenwinkel N, Lengauer T, Däumer M, Kaiser R, Walter H, Korn K, Hoffmann D, Selbig J. Methods for optimizing antiviral combination therapies. Bioinformatics. 2003; 19 Suppl 1:i16-25. PMID: 12855433.
      Citations: 11     Fields:    Translation:HumansCellsCTClinical Trials
    180. Herken H, Erdal ME, Aynacioglu AS, Barlas O, Cataloluk O, Esgi K, Brockmöller J, Kaiser R. Frequency of the 17-bp variable number of tandem repeat polymorphism in Turkish schizophrenic patients. Schizophr Res. 2002 Nov 01; 58(1):99-100. PMID: 12363397.
      Citations: 1     Fields:    Translation:HumansCells
    181. Kaiser R, Sezer O, Papies A, Bauer S, Schelenz C, Tremblay PB, Possinger K, Roots I, Brockmöller J. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J Clin Oncol. 2002 Jun 15; 20(12):2805-11. PMID: 12065557.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    182. Beerenwinkel N, Schmidt B, Walter H, Kaiser R, Lengauer T, Hoffmann D, Korn K, Selbig J. Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci U S A. 2002 Jun 11; 99(12):8271-6. PMID: 12060770.
      Citations: 61     Fields:    Translation:HumansCells
    183. Kaiser R, Geulen O, Matz B, Brackmann HH, Spengler U, Kramer MH, Exner M, Nettekoven W, Ko YD, Zeitler H, Vetter H. Risk of hepatitis C after immunoadsorption. Infect Control Hosp Epidemiol. 2002 Jun; 23(6):342-3. PMID: 12083240.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    184. Wasmuth JC, Herhaus C, Römer K, Salzberger B, Kaiser R, Schliefer K, Voigt E, Rockstroh JK. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks. AIDS. 2002 May 03; 16(7):1077-8. PMID: 11953478.
      Citations:    Fields:    Translation:Humans
    185. Bauer S, Störmer E, Kaiser R, Tremblay PB, Brockmöller J, Roots I. Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection. Biomed Chromatogr. 2002 May; 16(3):187-90. PMID: 11920943.
      Citations: 3     Fields:    Translation:Humans
    186. Kaiser R, Müller-Oerlinghausen B, Filler D, Tremblay PB, Berghöfer A, Roots I, Brockmöller J. Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter. Am J Med Genet. 2002 Apr 08; 114(3):323-8. PMID: 11920857.
      Citations: 21     Fields:    Translation:HumansCells
    187. Kaiser R, Tremblay PB, Roots I, Brockmöller J. Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem. 2002 Feb; 35(1):49-56. PMID: 11937078.
      Citations: 11     Fields:    Translation:HumansCells